|
|
 Previous Article | Table of Contents | Next Article 
Bone Marrow Failure in the Fanconi Anemia Group C Mouse Model
After DNA Damage
Madeleine Carreau,
Olga I. Gan,
Lili Liu,
Monica Doedens,
Colin McKerlie,
John E. Dick, and
Manuel Buchwald
From the Department of Genetics, Research Institute, Hospital for
Sick Children, Toronto, Ontario, Canada; Research Services and
Pathology, Sunnybrook Health Science Centre, University of Toronto,
North York, Ontario, Canada; and the Department of Molecular and
Medical Genetics, University of Toronto, Toronto, Ontario, Canada.
Fanconi anemia (FA) is a pleiotropic inherited disease that causes
bone marrow failure in children. However, the specific involvement of
FA genes in hematopoiesis and their relation to bone marrow (BM)
failure is still unclear. The increased sensitivity of FA cells to DNA
cross-linking agents such as mitomycin C (MMC) and diepoxybutane (DEB),
including the induction of chromosomal aberrations and delay in the G2
phase of the cell cycle, have suggested a role for the FA genes in DNA
repair, cell cycle regulation, and apoptosis. We previously reported
the cloning of the FA group C gene (FAC) and the generation of
a Fac mouse model. Surprisingly, the Fac  / mice
did not show any of the hematologic defects found in FA patients. To
better understand the relationship of FA gene functions to BM failure,
we have analyzed the in vivo effect of an FA-specific DNA damaging
agent in Fac / mice. The mice were found to be highly
sensitive to DNA cross-linking agents; acute exposure to MMC produced a
marked BM hypoplasia and degeneration of proliferative tissues and
caused death within a few days of treatment. However, sequential,
nonlethal doses of MMC caused a progressive decrease in all peripheral
blood parameters of Fac / mice. This treatment targeted
specifically the BM compartment, with no effect on other proliferative
tissues. The progressive pancytopenia resulted from a reduction in the
number of early and committed hematopoietic progenitors. These results
indicate that the FA genes are involved in the physiologic response of hematopoietic progenitor cells to DNA damage.
Blood, Vol. 91 No. 8 (April 15), 1998:
pp. 2737-2744
© 1998 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
X. Li, M. M. Le Beau, S. Ciccone, F.-C. Yang, B. Freie, S. Chen, J. Yuan, P. Hong, A. Orazi, L. S. Haneline, et al.
Ex vivo culture of Fancc-/- stem/progenitor cells predisposes cells to undergo apoptosis, and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy
Blood,
May 1, 2005;
105(9):
3465 - 3471.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Rollinson, J. M. Allan, G. R. Law, P. L. Roddam, M. T. Smith, C. Skibola, A. G. Smith, M. S. Forrest, K. Sibley, R. Higuchi, et al.
High-Throughput Association Testing on DNA Pools to Identify Genetic Variants that Confer Susceptibility to Acute Myeloid Leukemia
Cancer Epidemiol. Biomarkers Prev.,
May 1, 2004;
13(5):
795 - 800.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Reese, L. Liu, and S. L. Gerson
Repopulating defect of mismatch repair-deficient hematopoietic stem cells
Blood,
September 1, 2003;
102(5):
1626 - 1633.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Aube, M. Lafrance, C. Charbonneau, I. Goulet, and M. Carreau
Hematopoietic Stem Cells from Fancc-/- Mice Have Lower Growth and Differentiation Potential in Response to Growth Factors
Stem Cells,
September 1, 2002;
20(5):
438 - 447.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Rio, J. C. Segovia, H. Hanenberg, J. A. Casado, J. Martinez, K. Gottsche, N. C. Cheng, H. J. Van de Vrugt, F. Arwert, H. Joenje, et al.
In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice
Blood,
August 28, 2002;
100(6):
2032 - 2039.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Carreau, L. Liu, O. I. Gan, J. K. Hitzler, J. E. Dick, and M. Buchwald
Short-term granulocyte colony-stimulating factor and erythropoietin treatment enhances hematopoiesis and survival in the mitomycin C-conditioned Fancc-/- mouse model, while long-term treatment is ineffective
Blood,
July 30, 2002;
100(4):
1499 - 1501.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Koomen, N. C. Cheng, H. J. van de Vrugt, B. C. Godthelp, M. A. van der Valk, A. B. Oostra, M. Z. Zdzienicka, H. Joenje, and F. Arwert
Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice
Hum. Mol. Genet.,
February 1, 2002;
11(3):
273 - 281.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M L Gomes, D M. de mattos, R de souza freitas, R J. Bezerral, and M Bernardo-Filho
Study of the toxicological effect of mitomycin C in mice: alteration on the biodistribution of radiopharmaceuticals used for renal eva uations
Human and Experimental Toxicology,
April 1, 2001;
20(4):
193 - 197.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N. C. Cheng, H. J. van de Vrugt, M. A. van der Valk, A. B. Oostra, P. Krimpenfort, Y. de Vries, H. Joenje, A. Berns, and F. Arwert
Mice with a targeted disruption of the Fanconi anemia homolog Fanca
Hum. Mol. Genet.,
July 22, 2000;
9(12):
1805 - 1811.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. G. Dronkert, J. de Wit, M. Boeve, M. L. Vasconcelos, H. van Steeg, T. L. R. Tan, J. H. J. Hoeijmakers, and R. Kanaar
Disruption of Mouse SNM1 Causes Increased Sensitivity to the DNA Interstrand Cross-Linking Agent Mitomycin C
Mol. Cell. Biol.,
July 1, 2000;
20(13):
4553 - 4561.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
L. G. Korkina, I. B. Deeva, A. De Biase, M. Iaccarino, R. Oral, M. Warnau, and G. Pagano
Redox-dependent toxicity of diepoxybutane and mitomycin C in sea urchin embryogenesis
Carcinogenesis,
February 1, 2000;
21(2):
213 - 220.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. A. Gush, K.-L. Fu, M. Grompe, and C. E. Walsh
Phenotypic correction of Fanconi anemia group C knockout mice
Blood,
January 15, 2000;
95(2):
700 - 704.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Pagano, A. Zatterale, L. G, Korkina;, M. Carreau, and M. Buchwald
Mitomycin C-Induced DNA Damage in Fanconi Anemia: Cross-Linking or Redox-Mediated Effects?
Blood,
February 1, 1999;
93(3):
1116 - 1118.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Näf, G. M. Kupfer, A. Suliman, K. Lambert, and A. D. D'Andrea
Functional Activity of the Fanconi Anemia Protein FAA Requires FAC Binding and Nuclear Localization
Mol. Cell. Biol.,
October 1, 1998;
18(10):
5952 - 5960.
[Abstract]
[Full Text]
|
|
|
| |
